Stay updated with breaking news from Preclinical Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
12.08.2022 - Cash runway expected to extend from 2024 into 2025 upon completion of anticipated sale-leaseback of Tarzana, CA manufacturing site DELTA-1 trial of ITIL-168 in advanced melanoma with registrational intent anticipated to complete enrollment in 1H ...
Kinarus AG / Key word(s): Patent Positive Preclinical Data for KIN001 in wet Age-Related Macular Degeneration - Plans for Clinical Development 10.05.2022 / 09:45 MEDIA RELEASE (PDF) KIN001 reduced formation of leaky blood vessels and reduced retinal fibrosis in preclinical models of wet Age-Rela...
28.04.2022 - Seagen Inc. (Nasdaq:SGEN) reported financial results today for the first quarter ended March 31, 2022. The Company also highlighted PADCEV (enfortumab vedotin-ejfv), TUKYSA (tucatinib), ADCETRIS (brentuximab vedotin) and TIVDAK (tisotumab ...
/PRNewswire/ -- The Guarantors of EQIPD e.V. (GoEQIPD) announce the formation of a registered association, based in Heidelberg Germany, to host and to ensure...
Voyager Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results License option agreement with Novartis for target-specific access... | March 8, 2022